focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Appointment of Independent Bo

18 Aug 2008 07:00

RNS Number : 4921B
Phorm Inc
18 August 2008
 



Phorm, Inc. ("Phorm" or the "Company") 

Phorm Elects Steven J. Heyer as Independent Board Chairman 

Phorm (AIM: PHRM and PHRX), the advertising technology company, today announces the election of Non-Executive Director, Steven J. Heyer, as Board Chairman. Kent Ertugrul will continue to lead the Company as Chief Executive Officer, driving the implementation of Phorm's business strategy and technology. The appointment takes effect immediately and will strengthen Phorm's corporate governance while providing a solid leadership platform for future growth as the Company moves to the next stage of its development.

Mr. Heyer, aged 56, joined the Phorm Board in October 2007 and brings with him over three decades of global management experience, strong marketing skills and a deep knowledge of the development of brands. He is the Co-Chairman and CEO of Fathom Studios, a CG animation company, and the former CEO of Starwood Hotels & Resorts Worldwide; President and COO of Coca-Cola Company; President and COO of Turner Broadcasting System, Inc.; and President and COO of Young and Rubicam, Inc. Mr. Heyer is also a member of the Board of Directors of Lazard Group, Omnicare Inc., Vitrue Inc., a social networking company, NCAA, and Special Olympics.

Kent Ertugrul, Chief Executive Officer of Phorm, Inc., said: "Splitting the role of Chairman and Chief Executive will enable me to focus more of my time and efforts on driving our vision. I am very pleased to be working even more closely with Steve. Steve's broad business experience, commercial acumen and deep knowledge of the media, advertising and ISP industries will continue to prove invaluable to Phorm going forward. Our collaboration has proved very effective in implementing our vision for Phorm. We have the right strategy in place and great momentum and I am confident this change will further strengthen our business."

Steven Heyer commented: "Kent and the management team have made very significant progress in executing the Company's strategy, developing Phorm's proprietary technology platform and building strong relationships with ISPs, advertisers and publishers. Our strategy is sound and, as Chairman, I look forward to working even more closely with Kent, our team and our partners. We are all very enthusiastic about Phorm's future growth potential. The Board is committed to positioning the Company for success and delivering value to our shareholders."

For Phorm Enquiries:

Lynne Millar (Chief Financial Officer) +44 20 7638 9571

Citigate Dewe Rogerson +44 20 7638 9571

Simon Rigby

Justin Griffiths

Canaccord Adams Limited +44 20 7050 6500

(Nominated Advisor)

Mark Williams

Andrew Chubb

About Phorm: 

Phorm is an innovative technology company specialising in delivering behaviourally and contextually targeted advertising while preserving users' personal privacy and security. 

Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

Phorm is a Delaware corporation, with offices in New York, London and Moscow. The Company was admitted to the AIM market of the London Stock Exchange in 2004 and has over 100 employees.

For more information, please visit: www.phorm.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPRMJTMMMBTLP

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.